Novo was first in the market,got CMS Medicare approval with Narrow Pipeline of Drugs only on Weight loss & Diabetes (Front runner Semaglutide) Lilly has better Efficacy Drug(Tirzepatide & Pipeline drugs) for Wt loss/Diabetes,Longer IP Patent Runway till mid 2030s with better Growth Penetration With Wider Pipeline of Pharma drugs including Oncology/ Neurology/ Immunology/ Inflammation,Urology- Erectile Dysfunction,Osteoporosis in Men and Women and afford to run the price war with Novo and wipeout their Business Eli Lilly is winning hands down
Determining Candidacy for Semaglutide Treatment Semaglutide weight loss treatment could be ideal if your BMI is 30 or higher, or 27 with a weight-related condition such as type 2 diabetes, high blood pressure, or hypercholesterolemia
D., Rogdaki, M., Findon, J
From there, your doctor may increase your dose by 2.5 mg increments every month, depending on your treatment goals and how your body responds
In 2021, Kristin launched her own weight loss coaching program
The tirzepatide before and after results page shows outcomes from both branded and compounded protocols